EP3805248

• Genentech, Inc.; Novartis AGseit 12. März 2021

The present disclosure provides a process for concentrating proteins including an ultrafiltering, a diafiltering, and a second ultrafiltering sequence, at elevated temperatures, such as above about 30°C. The disclosure also includes a process for preparing highly concentrated antibody compositions, and highly concentrated antibody products.